Skip to main content
SpringerLink
Log in

Transsexualität

  • Chapter
Medizinische Therapie 2005|2006

  • 73 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Asscheman H, Gooren LJG, Assies J, Smits JPH, De Slegte R (1988) Prolactin levels and pituitary enlargement in hormone-treated mal-to-female transsexuals. Clin Endocrinol 28: 583–588

    CAS  Google Scholar 

  • Bakker A, van Kesteren PJ, Gooren LJ, Bezemer PD (2002) The prevalence of transsexualism in the Netherlands. Acta Psychiatr Scand 87: 237–238

    Google Scholar 

  • Cohen-Kettenis PT, Gooren LJ (1999) Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res 46: 315–333

    Article  CAS  PubMed  Google Scholar 

  • Damewood MD, Bellantoni JJ, Bachorik PS, Kimball AW Jr, Roch JA (1989) Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males. J Endocrinol Invest 12: 449–454

    CAS  PubMed  Google Scholar 

  • Dorner G, Poppe I, Stahl F, Kolzsch J, Uebelhack R (1991) Gene-and environment-dependent neuroendocrine etiogenesis of homosexuality and transsexualism. Exp Clin Endocrinol 98: 141–150

    CAS  PubMed  Google Scholar 

  • Eicher W, Schmitt B, Bergner CM (1991) Transformationsoperation bei Mann-zu-Frau-Transsexuellen. Z Sexualforsch 4: 119–132

    Google Scholar 

  • Eicher W (1992) Transsexualismus, 2. Auflage. Gustav Fischer, Stuttgart

    Google Scholar 

  • Gesetz über die Änderung der Vornamen und die Feststellung der Geschlechtszugehörigkeit in besonderen Fällen (Transsexuellengesetz — TSG) (1980) Bundesgesetzblatt, Jahrgang 1980, Teil I

    Google Scholar 

  • Goh HH, Ratnam SS (1990) Effects of estrogens on prolactin secretion in transsexual subjects. Arch Sex Behav 19: 507–516

    CAS  PubMed  Google Scholar 

  • Kemper J (1992) Sexualtherapeutische Praxis. J. Pfeiffer, München

    Google Scholar 

  • Kokott G (1988) Sexuelle Variationen. In: Faust V (Hrsg) Psychiatrie für den Praxisalltag. Hippokrates, Stuttgart, S 63–78

    Google Scholar 

  • Kovacs K (1999) Prolactin-producing pituitary adenoma in a male-to-femaletranssexual patient with protracted estrogen administration. Arch Pathol Lab Med 118: 562–565

    Google Scholar 

  • Liedl B (1999) Geschlechtsangleichende Operationen bei Transsexualität. MMW Fortschr Med 41(23): 305–309

    Google Scholar 

  • Moore E, Wisniewski A, Dobs A (2003) Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88: 3467–3473

    Article  CAS  PubMed  Google Scholar 

  • Pfäfflin F (1993) Transsexualität. Enke, Stuttgart

    Google Scholar 

  • Poland D (1991) Transsexualität — Leitsymptomatik, Differentialdiagnostik und Behandlungskonzepte. In: Kamprad B; Schiffels W (Hrsg) Im falschen Körper. Alles über Transsexualität. Keuz, Zürich, S 70–83

    Google Scholar 

  • Schlatterer K, Werder K von, Stalla GK (1996) Multistepp treatment concept of transsexual patients. Clin Endocrinol Diabetes 104: 413–419

    CAS  Google Scholar 

  • Schlatterer K, Auer DP, Yassouridis A, Werder K von, Stalla GK (1998) Transsexualism and osteoporosis. Clin Endocrinol Diabetes 106: 365–368

    CAS  Google Scholar 

  • Schlatterer K, Yassouridis A, Werder K von, Poland D, Kemper J, Stalla GK (1998) A follow-up study for estimating the effectiveness of a crossgender hormone substitution therapy on transsexual patients. Arch Sex Behav 27(5), 475–492

    Article  CAS  PubMed  Google Scholar 

  • Sigusch V (1994) Leitsymptome transsexueller Entwicklungen. Dtsch Ärztebl 91(20): B1085–B1088

    Google Scholar 

  • Toorians AWFT, Thomassen MCLGD, Zweegman S, Magdelyns EJP, Tans G, Gooren LJ, Rosing J (2003) Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 88: 5723–5729

    CAS  PubMed  Google Scholar 

  • Van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol 47: 337–342

    Google Scholar 

  • Zhou JN, Hofman MA, Gooren LJ, Swaab DF (1995) A sex difference in the human brain and its relation to transsexuality. Nature 378: 68–70

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Harald Jörn Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ludwig Schaaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Günter Karl Stalla
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, D-93042, Regensburg

    Jürgen Schölmerich

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Schneider, H.J., Schaaf, L., Stalla, G.K. (2005). Transsexualität. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_65

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_65

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation